Researcher: Kara, İlayda Arjen
Name Variants
Kara, İlayda Arjen
Email Address
Birth Date
1 results
Search Results
Now showing 1 - 1 of 1
Publication Open Access Systematic review and meta-analysis of postexposure prophylaxis for Crimean-Congo hemorrhagic fever virus among healthcare workers(Centers for Disease Control and Prevention (CDP), 2018) Keske, Şiran; Pshenichnaya, Natalia; Abuova, Gulzhan; Blumberg, Lucille; Gönen, Mehmet; N/A; Ergönül, Önder; Çeldir, Melis Gökçe; Kara, İlayda Arjen; Faculty Member; School of Medicine; Graduate School of Health Sciences; 110398; N/A; N/AWe performed a systematic review and meta-analysis on the effectiveness of ribavirin use for the prevention of infection and death of healthcare workers exposed to patients with Crimean-Congo hemorrhagic fever virus (CCHFV) infection. Splashes with blood or bodily fluids (odds ratio [OR] 4.2), being a nurse or physician (OR 2.1), and treating patients who died from CCHFV infection (OR 3.8) were associated with healthcare workers acquiring CCHFV infection; 7% of the workers who received postexposure prophylaxis (PEP) with ribavirin and 89% of those who did not became infected. PEP with ribavirin reduced the odds of infection (OR 0.01, 95% CI 0-0.03), and ribavirin use <= 48 hours after symptom onset reduced the odds of death (OR 0.03, 95% CI 0-0.58). The odds of death increased 2.4-fold every day without ribavirin treatment. Ribavirin should be recommended as PEP and early treatment for workers at medium-to-high risk for CCHFV infection.